Pharmaceutical and biotechnology company, which is focused on preparing messenger RNA (mRNA) vaccines, Moderna, Inc. (MRNA) recently announced that it has entered into a revised supply agreement with the UK government for the delivery of additional COVID-19 vaccine doses. Terms of the Agreement Under the terms of the agreement, Moderna will deliver up to 60 million doses of its COVID-19 vaccine (29 million doses expected to be delivered in 2022 and up to 31 million doses expected to be delivered in 2023). The delivered vaccines may also include booster doses.
https://www.tipranks.com/news/moderna-to-supply-additional-covid-19-vaccines-to-the-uk?utm_source=advfn.com&utm_medium=referral
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Moderna Charts.